Safety, tolerability and pharmacodynamics of TAK-906, a dopamine 2,3 antagonist, in patients with diabetic or idiopathic gastroparesis

首页> 外文期刊>Neurogastroenterology and motility >Safety, tolerability and pharmacodynamics of TAK-906, a dopamine 2,3 antagonist, in patients with diabetic or idiopathic gastroparesis

【24h】

Safety, tolerability and pharmacodynamics of TAK-906, a dopamine 2,3 antagonist, in patients with diabetic or idiopathic gastroparesis

机译：糖尿病或特发性胃病患者的多巴胺2,3拮抗剂Tak-906的安全性，耐受性和药效学和药效学

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Neurogastroenterology and motility》 |2019年第s3期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Safety, tolerability and pharmacodynamics of TAK-906, a dopamine 2,3 antagonist, in patients with diabetic or idiopathic gastroparesis [J] . Neurogastroenterology and motility . 2019,第S3期

机译：糖尿病或特发性胃病患者的多巴胺2,3拮抗剂Tak-906的安全性，耐受性和药效学和药效学
2. Phase 1 randomized study on the safety, tolerability, and pharmacodynamic cognitive and electrophysiological effects of a dopamine D ₁ receptor positive allosteric modulator in patients with schizophrenia [J] . Amit Desai, Lauren Benner, Ruishan Wu, Neuropsychopharmacology . 2021,第6期

机译：第1期随机研究了精神分裂症患者的多巴胺D _{1 受体阳性血糖激素调节剂的安全性，耐受性和药效学认知和电生理学作用}
3. Randomized Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Topical Daprodustat in Healthy Volunteers and in Patients With Diabetic Foot Ulcers [J] . Olson Eric, Mahar Kelly M., Morgan Lisa, Clinical pharmacology in drug development . 2019,第6期

机译：随机阶段I试验，以评估局部Daprodustat在健康志愿者和糖尿病足溃疡患者中的局部Daprodustat的安全性，耐受性，药代动力学和药效学
4. Electrogastrography in Patients with Diabetic Gastroparesis [C] . Abdullah al Kafee, Sevim Eryigit, Aydin Akan Medical Technologies National Congress . 2017

机译：患有糖尿病胃病患者的电池术
5. The safety and tolerability of regadenoson in patients with end stage renal disease. [D] . Rangel, Maria Octavia. 2013

机译：regadenoson在晚期肾病患者中的安全性和耐受性。
6. Evaluation of the Pharmacokinetics of Trazpiroben (TAK-906) a Peripherally Selective D2/D3 Dopamine Receptor Antagonist in the Presence and Absence of Itraconazole a Potent CYP 3A4 Inhibitor [O] . Chunlin Chen, Wenwen Zhang, Muhammad Bari, 2021

机译：评价赤血管（TAK-906）的药代动力学在外周选择性D2 / D3多巴胺受体拮抗剂在伊唑康唑的存在和不存在下有效的CYP 3A4抑制剂
7. Efficacy and Safety of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial [O] . Jesse L. Carlin, V. Rose Lieberman, Arya Dahal, 2021

机译：随机，安慰剂对照试验中糖尿病患者患者的疗效和安全性

Safety, tolerability and pharmacodynamics of TAK-906, a dopamine 2,3 antagonist, in patients with diabetic or idiopathic gastroparesis

著录项

引文网络

相似文献

相关主题

期刊订阅